# Levetiracetam

## Keppra inj 500mg/5mL

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IKEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 適應症     | Focal (partial) onset: Adjunctive therapy in the treatment of focal (partial) onset seizures in adults and children >=4 years of age and >20 kg with epilepsy. Generalized onset: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years and older with juvenile myoclonic epilepsy. Primary generalized tonic-clonic seizures: Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and 16 years and older with idiopathic generalized epilepsy.                                                                                                                                                                                                                                                                                                                                               |
| 用法用量   | monotherapy: Adults, 16 Years and Older: Initial, 250 mg twice daily IV/orally; titration, may increase by increments of 500 mg/day every 2 weeks in 2 divided doses to MAX, 3000 mg/day. adjunctive therapy: Adults, 18 Years and Older; 12-17 years older with weighing >50 kg : Initial: 1000 mg on DAY1 (500mg twice daily); increase or decrease every 2-4 weeks by 1 g/day based on response and tolerability to a maximum of 3 g once daily. 4-11 years old children and 12-17 years old with weighing <50 kg: Initial: 10 mg/kg twice daily, increase/decrease 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily.                                                                                                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 禁忌       | Hypersensitivity to levetiracetam.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 副作用     | Common Gastrointestinal: Loss of appetite (3% to 8% ), Vomiting (15% ) Immunologic: Infectious disease (13% ) Musculoskeletal: Decreased bone mineral density (70% ), Neck pain (2% to 8% ) Neurologic: Asthenia (15% ), Dizziness (5% to 9% ), Headache (14% to 19% ) Psychiatric: Abnormal behavior (7% to 37.6% ), Irritability (6% to 12% ) Respiratory: Cough (2% to 9% ), Nasopharyngitis (7% to 15% ) Other: Fatigue (10% to 11% ) Serious Dermatologic: Stevens-Johnson syndrome, Toxic epidermal necrolysis due to drug Hematologic: Decreased erythrocyte production, Decreased white blood cell count (2.4% to 3.2% ), Eosinophil count raised (8.6% ), Neutropenia ( 2.4% ), Pancytopenia, Thrombocytopenia Hepatic: Liver failure Immunologic: Anaphylaxis Neurologic: Somnolence (8% to 45% ) Psychiatric: Suicidal intent (0.5% ), Suicide Other: Angioedema |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

## Keppra solution 100mg/mL， 300mL

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | LKEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 適應症     | Focal (partial) onset: Adjunctive therapy in the treatment of focal (partial) onset seizures in adults and children ?4 years of age and >20 kg with epilepsy. Generalized onset: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years and older with juvenile myoclonic epilepsy. Primary generalized tonic-clonic seizures: Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and 16 years and older with idiopathic generalized epilepsy.                                                                                                                                                                                                                                                                                                                                                |
| 用法用量   | monotherapy: Adults, 16 Years and Older: Initial, 250 mg twice daily IV/orally; titration, may increase by increments of 500 mg/day every 2 weeks in 2 divided doses to MAX, 3000 mg/day. adjunctive therapy: Adults, 18 Years and Older; 12-17 years older with weighing >50 kg : Initial: 1000 mg on DAY1 (500mg twice daily); increase or decrease every 2-4 weeks by 1 g/day based on response and tolerability to a maximum of 3 g once daily. 4-11 years old children and 12-17 years old with weighing <50 kg: Initial: 10 mg/kg twice daily, increase/decrease 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily.                                                                                                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 禁忌       | Hypersensitivity to levetiracetam.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 副作用     | Common Gastrointestinal: Loss of appetite (3% to 8% ), Vomiting (15% ) Immunologic: Infectious disease (13% ) Musculoskeletal: Decreased bone mineral density (70% ), Neck pain (2% to 8% ) Neurologic: Asthenia (15% ), Dizziness (5% to 9% ), Headache (14% to 19% ) Psychiatric: Abnormal behavior (7% to 37.6% ), Irritability (6% to 12% ) Respiratory: Cough (2% to 9% ), Nasopharyngitis (7% to 15% ) Other: Fatigue (10% to 11% ) Serious Dermatologic: Stevens-Johnson syndrome, Toxic epidermal necrolysis due to drug Hematologic: Decreased erythrocyte production, Decreased white blood cell count (2.4% to 3.2% ), Eosinophil count raised (8.6% ), Neutropenia ( 2.4% ), Pancytopenia, Thrombocytopenia Hepatic: Liver failure Immunologic: Anaphylaxis Neurologic: Somnolence (8% to 45% ) Psychiatric: Suicidal intent (0.5% ), Suicide Other: Angioedema |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

## Keppra 500mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OKEP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 適應症     | Focal (partial) onset: Adjunctive therapy in the treatment of focal (partial) onset seizures in adults and children ?4 years of age and >20 kg with epilepsy. Generalized onset: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years and older with juvenile myoclonic epilepsy. Primary generalized tonic-clonic seizures: Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and 16 years and older with idiopathic generalized epilepsy.                                                                                                                                                                                                                                                                                                                                                |
| 用法用量   | Monotherapy: Adults, 16 Years and Older: Initial, 250 mg twice daily IV/orally; titration, may increase by increments of 500 mg/day every 2 weeks in 2 divided doses to MAX, 3000 mg/day. adjunctive therapy: Adults, 18 Years and Older; 12-17 years older with weighing >50 kg : Initial: 1000 mg on DAY1 (500mg twice daily); increase or decrease every 2-4 weeks by 1 g/day based on response and tolerability to a maximum of 3 g once daily. 4-11 years old children and 12-17 years old with weighing <50 kg: Initial: 10 mg/kg twice daily, increase/decrease 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily.                                                                                                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 禁忌       | Hypersensitivity to levetiracetam.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 副作用     | Common Gastrointestinal: Loss of appetite (3% to 8% ), Vomiting (15% ) Immunologic: Infectious disease (13% ) Musculoskeletal: Decreased bone mineral density (70% ), Neck pain (2% to 8% ) Neurologic: Asthenia (15% ), Dizziness (5% to 9% ), Headache (14% to 19% ) Psychiatric: Abnormal behavior (7% to 37.6% ), Irritability (6% to 12% ) Respiratory: Cough (2% to 9% ), Nasopharyngitis (7% to 15% ) Other: Fatigue (10% to 11% ) Serious Dermatologic: Stevens-Johnson syndrome, Toxic epidermal necrolysis due to drug Hematologic: Decreased erythrocyte production, Decreased white blood cell count (2.4% to 3.2% ), Eosinophil count raised (8.6% ), Neutropenia ( 2.4% ), Pancytopenia, Thrombocytopenia Hepatic: Liver failure Immunologic: Anaphylaxis Neurologic: Somnolence (8% to 45% ) Psychiatric: Suicidal intent (0.5% ), Suicide Other: Angioedema |
| 孕期建議   | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

